摘要目的 评估经皮血管成形术在治疗移植肾动脉狭窄(TRAS)导致的移植肾功能损害和(或)高血压中的效果.方法 回顾性分析1998年7月至2007年1月经皮肾动脉造影明确诊断为移植肾动脉狭窄的16例患者的临床资料.在16例患者被确诊前先行多普勒超声检查,有13例被发现TRAS,3例阴性,假阴性率为18.75%.对16例TRAS患者均采取经皮血管成形术治疗.术后对患者进行了3年的随访,分别在术后1周、6个月、1年、2年和3年时评估肾功能和高血压改善状况.以平均动脉压较术前下降至少15%定义为高血压改善;以血清肌酐降低至少20%定义为移植肾功能改善.结果 经皮血管成形术成功率100%,16例患者经治疗后均获临床治愈.术后1周、6个月、1年、2年和3年时,肾功能改善率分别为81.25%、68.75%、62.5%、56.25%和50%,高血压改善率分别为62.5%、75%、75%、56.25%和50%,所有患者服用降血压药物的种类和用量均减少.结论 经皮血管成形术对TRAS导致的肾功能损害和高血压有明显的改善作用,是安全和有效的治疗方法 .

abstractsObjective To evaluate the efficacy of percutaneous transluminal angioplasty (PTA) in the treatment of transplanted renal artery stenosis (TRAS)-induced renal dysfunction and hypertension. Methods Between July 1998 and January 2007, PTA was performed on 16 patients with RTAS. Color Doppler uhrasonography preceded the intra-arterial angiographic investigation,with false-negative results in 18. 75 % of patients. Sixteen cases of TRAS were examined at 1 st week,6th month and 13 years after PTA. Hypertension improvement was defined as mean arterial pressure decrease of at least 15 % from the pre-PTA value. Graft function was evaluated by SCr levels, and the improvement was defined as a 20% change. Results Angioplasty was technically feasible in 100 %.Sixteen patients with RTAS were cured clinically. During the follow-up period, graft function was improved in 81.25 %, 68. 75 %, 62. 5 %, 56. 25 %, 50 % of patients respectively at 1st week, 6th month and 1-3 years after PTA. The blood pressure was decreased in 62. 5%, 75 %, 75 %,56. 25 %, 50 % of patients respectively, but no patient remained hypotensor medication free.Conclusion PTA improved renal dysfunction and hypertension induced by TRAS, and it is a safe and effective treatment for TRAS.